# Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma

> **NCT03138031** · NA · COMPLETED · sponsor: **The National Ribat University** · enrollment: 23 (actual)

## Conditions studied

- Hepatocellular Carcinoma Non-resectable

## Interventions

- **PROCEDURE:** Percutaneous ethanol alcohol injection

## Key facts

- **NCT ID:** NCT03138031
- **Lead sponsor:** The National Ribat University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03138031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03138031, "Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03138031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*